Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP120145.RA48K8GltWqoIFaLvFt1jWOlCwndNrDiWSq0-DHYRPH-A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP120145.RA48K8GltWqoIFaLvFt1jWOlCwndNrDiWSq0-DHYRPH-A130_assertion type Assertion NP120145.RA48K8GltWqoIFaLvFt1jWOlCwndNrDiWSq0-DHYRPH-A130_head.
- NP120145.RA48K8GltWqoIFaLvFt1jWOlCwndNrDiWSq0-DHYRPH-A130_assertion description "[PcG protein EZH2 is associated with adverse pathological features and clinical PSA recurrence of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP120145.RA48K8GltWqoIFaLvFt1jWOlCwndNrDiWSq0-DHYRPH-A130_provenance.
- NP120145.RA48K8GltWqoIFaLvFt1jWOlCwndNrDiWSq0-DHYRPH-A130_assertion evidence source_evidence_literature NP120145.RA48K8GltWqoIFaLvFt1jWOlCwndNrDiWSq0-DHYRPH-A130_provenance.
- NP120145.RA48K8GltWqoIFaLvFt1jWOlCwndNrDiWSq0-DHYRPH-A130_assertion SIO_000772 17134822 NP120145.RA48K8GltWqoIFaLvFt1jWOlCwndNrDiWSq0-DHYRPH-A130_provenance.
- NP120145.RA48K8GltWqoIFaLvFt1jWOlCwndNrDiWSq0-DHYRPH-A130_assertion wasDerivedFrom lhgdn-20090331 NP120145.RA48K8GltWqoIFaLvFt1jWOlCwndNrDiWSq0-DHYRPH-A130_provenance.
- NP120145.RA48K8GltWqoIFaLvFt1jWOlCwndNrDiWSq0-DHYRPH-A130_assertion wasGeneratedBy ECO_0000203 NP120145.RA48K8GltWqoIFaLvFt1jWOlCwndNrDiWSq0-DHYRPH-A130_provenance.